|
|||||
|
|
Correction to: Exploratory Prognostic Biomarkers of Complement-Mediated Thrombotic Microangiopathy (CM-TMA) in Adults with Atypical Hemolytic Uremic Syndrome (aHUS): Analysis of a Phase III Study of Ravulizumab |
|
| Authors: | Cammett Tobin J Garlo Katherine Millman Ellen E Rice Kara Toste Catherine M Faas Susan J |
| Institution: | 1.Alexion, AstraZeneca Rare Disease, Boston, MA, USA ; |
| Abstract: | Molecular Diagnosis & Therapy - |
| Keywords: | |
| 本文献已被 SpringerLink 等数据库收录！ | |